Plasma therapy: a passive resistance against the deadliest
Convalescent plasma therapy provides a useful therapeutic tool to treat infectious diseases, especially where no specific therapeutic strategies have been identified. The ongoing pandemic puts back the spotlight on this age-old method as a viable treatment option. In this review, we discuss the usag...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-04-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/21645515.2021.2006026 |
| _version_ | 1797673245991763968 |
|---|---|
| author | Anita Hansda Debarati Biswas Aishwarya Bhatta Nishant Chakravorty Gayatri Mukherjee |
| author_facet | Anita Hansda Debarati Biswas Aishwarya Bhatta Nishant Chakravorty Gayatri Mukherjee |
| author_sort | Anita Hansda |
| collection | DOAJ |
| description | Convalescent plasma therapy provides a useful therapeutic tool to treat infectious diseases, especially where no specific therapeutic strategies have been identified. The ongoing pandemic puts back the spotlight on this age-old method as a viable treatment option. In this review, we discuss the usage of this therapy in different diseases including COVID-19, and the possible mechanisms of action. The current review also discusses the progress of therapeutic applications of blood-derivatives, from the simple transfer of immunized animal sera, to the more target-specific intravenous administration of human immunoglobulins from a pool of convalescent individuals, in both infectious and non-infectious diseases of various etiologies. |
| first_indexed | 2024-03-11T21:42:46Z |
| format | Article |
| id | doaj.art-6b080074267d4e54825c95082741a617 |
| institution | Directory Open Access Journal |
| issn | 2164-5515 2164-554X |
| language | English |
| last_indexed | 2024-03-11T21:42:46Z |
| publishDate | 2022-04-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj.art-6b080074267d4e54825c95082741a6172023-09-26T12:53:16ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2022-04-0118210.1080/21645515.2021.20060262006026Plasma therapy: a passive resistance against the deadliestAnita Hansda0Debarati Biswas1Aishwarya Bhatta2Nishant Chakravorty3Gayatri Mukherjee4Indian Institute of Technology KharagpurIndian Institute of Technology KharagpurIndian Institute of Technology KharagpurIndian Institute of Technology KharagpurIndian Institute of Technology KharagpurConvalescent plasma therapy provides a useful therapeutic tool to treat infectious diseases, especially where no specific therapeutic strategies have been identified. The ongoing pandemic puts back the spotlight on this age-old method as a viable treatment option. In this review, we discuss the usage of this therapy in different diseases including COVID-19, and the possible mechanisms of action. The current review also discusses the progress of therapeutic applications of blood-derivatives, from the simple transfer of immunized animal sera, to the more target-specific intravenous administration of human immunoglobulins from a pool of convalescent individuals, in both infectious and non-infectious diseases of various etiologies.http://dx.doi.org/10.1080/21645515.2021.2006026convalescent plasmaneutralizing antibodies (nabs)intravenous immunoglobulin (ivig) |
| spellingShingle | Anita Hansda Debarati Biswas Aishwarya Bhatta Nishant Chakravorty Gayatri Mukherjee Plasma therapy: a passive resistance against the deadliest Human Vaccines & Immunotherapeutics convalescent plasma neutralizing antibodies (nabs) intravenous immunoglobulin (ivig) |
| title | Plasma therapy: a passive resistance against the deadliest |
| title_full | Plasma therapy: a passive resistance against the deadliest |
| title_fullStr | Plasma therapy: a passive resistance against the deadliest |
| title_full_unstemmed | Plasma therapy: a passive resistance against the deadliest |
| title_short | Plasma therapy: a passive resistance against the deadliest |
| title_sort | plasma therapy a passive resistance against the deadliest |
| topic | convalescent plasma neutralizing antibodies (nabs) intravenous immunoglobulin (ivig) |
| url | http://dx.doi.org/10.1080/21645515.2021.2006026 |
| work_keys_str_mv | AT anitahansda plasmatherapyapassiveresistanceagainstthedeadliest AT debaratibiswas plasmatherapyapassiveresistanceagainstthedeadliest AT aishwaryabhatta plasmatherapyapassiveresistanceagainstthedeadliest AT nishantchakravorty plasmatherapyapassiveresistanceagainstthedeadliest AT gayatrimukherjee plasmatherapyapassiveresistanceagainstthedeadliest |